Medicine Vorasidenib approved in UK for treating IDH-mutant brain tumours By admin September 17, 2025September 17, 2025 0 Comment on Vorasidenib approved in UK for treating IDH-mutant brain tumours
Medicine Imfinzi approved for NHS use in limited-stage small cell lung cancer By admin September 16, 2025September 16, 2025 0 Comment on Imfinzi approved for NHS use in limited-stage small cell lung cancer
Medicine SOM Biotech receives EMA backing for Huntington’s disease drug By admin September 16, 2025 0 Comment on SOM Biotech receives EMA backing for Huntington’s disease drug
Medicine Dr Christian Dowdeswell – PharmaTimes By admin September 15, 2025 0 Comment on Dr Christian Dowdeswell – PharmaTimes
Medicine Lundbeck unveils migraine data for eptinezumab at international congress By admin September 12, 2025 0 Comment on Lundbeck unveils migraine data for eptinezumab at international congress
Medicine Capvaxive shows strong immune response in children at risk of pneumococcal disease By admin September 11, 2025 0 Comment on Capvaxive shows strong immune response in children at risk of pneumococcal disease
Medicine George Eldridge – PharmaTimes By admin September 11, 2025 0 Comment on George Eldridge – PharmaTimes
Medicine Rezatapopt shows promise in phase 2 trial for TP53 Y220C solid tumours By admin September 10, 2025September 10, 2025 0 Comment on Rezatapopt shows promise in phase 2 trial for TP53 Y220C solid tumours
Medicine Bluejay begins phase 3 trial of brelovitug for hepatitis D By admin September 10, 2025 0 Comment on Bluejay begins phase 3 trial of brelovitug for hepatitis D
Medicine Quotient Sciences and CPI launch RNA drug development venture By admin September 9, 2025 0 Comment on Quotient Sciences and CPI launch RNA drug development venture
Medicine Eisai unveils promising phase 1b data for narcolepsy drug E2086 By admin September 9, 2025September 9, 2025 0 Comment on Eisai unveils promising phase 1b data for narcolepsy drug E2086
Medicine Sharon Curran – PharmaTimes By admin September 8, 2025 0 Comment on Sharon Curran – PharmaTimes
Medicine AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025 By admin September 5, 2025 0 Comment on AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025
Medicine Resolution Therapeutics doses first patient in EMERALD study of RTX001 By admin September 4, 2025September 4, 2025 0 Comment on Resolution Therapeutics doses first patient in EMERALD study of RTX001
Medicine eXmoor and Anthony Nolan partner to streamline cell therapy development By admin September 3, 2025September 3, 2025 0 Comment on eXmoor and Anthony Nolan partner to streamline cell therapy development
Medicine Polpharma Biologics and MS Pharma partner to expand biosimilar access By admin September 2, 2025 0 Comment on Polpharma Biologics and MS Pharma partner to expand biosimilar access
Medicine Lilly receives UK approval for pirtobrutinib in relapsed blood cancers By admin September 2, 2025 0 Comment on Lilly receives UK approval for pirtobrutinib in relapsed blood cancers
Medicine FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease By admin September 1, 2025September 1, 2025 0 Comment on FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease
Medicine Coya Therapeutics to progress trial of ALS treatment upon FDA approval By admin August 29, 2025 0 Comment on Coya Therapeutics to progress trial of ALS treatment upon FDA approval
Medicine Akiram advances trial of targeted radiotherapy for solid tumours By admin August 28, 2025 0 Comment on Akiram advances trial of targeted radiotherapy for solid tumours
Medicine Johnny Cheng appointed as interim CEO of HUTCHMED By admin August 28, 2025 0 Comment on Johnny Cheng appointed as interim CEO of HUTCHMED
Medicine Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach By admin August 27, 2025 0 Comment on Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach
Medicine Anne White to retire as head of Lilly Neuroscience after three decades at company By admin August 27, 2025August 27, 2025 0 Comment on Anne White to retire as head of Lilly Neuroscience after three decades at company
Medicine Novartis blood disorder drug shows promise in late-stage trial By admin August 26, 2025 0 Comment on Novartis blood disorder drug shows promise in late-stage trial
Medicine Fertile ground – PharmaTimes By admin August 25, 2025 0 Comment on Fertile ground – PharmaTimes
Medicine Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data By admin August 22, 2025 0 Comment on Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
Medicine ANGLE partners with Myriad Genetics to explore blood-based cancer testing By admin August 21, 2025 0 Comment on ANGLE partners with Myriad Genetics to explore blood-based cancer testing
Medicine FDA grants Breakthrough Therapy Designation to lung cancer therapy By admin August 20, 2025 0 Comment on FDA grants Breakthrough Therapy Designation to lung cancer therapy
Medicine Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford By admin August 19, 2025 0 Comment on Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
Medicine Upperton and Oxford join forces to develop oral vaccine formulation By admin August 19, 2025 0 Comment on Upperton and Oxford join forces to develop oral vaccine formulation
Medicine Ogsiveo approved in EU for treatment of desmoid tumors By admin August 18, 2025 0 Comment on Ogsiveo approved in EU for treatment of desmoid tumors
Medicine Mounjaro shows cardiovascular benefit in head-to-head diabetes trial By admin August 15, 2025 0 Comment on Mounjaro shows cardiovascular benefit in head-to-head diabetes trial
Medicine Vedanta’s ulcerative colitis candidate misses phase 2 efficacy target By admin August 14, 2025August 14, 2025 0 Comment on Vedanta’s ulcerative colitis candidate misses phase 2 efficacy target
Medicine Genmab’s epcoritamab combination meets key endpoints in phase 3 lymphoma trial By admin August 14, 2025 0 Comment on Genmab’s epcoritamab combination meets key endpoints in phase 3 lymphoma trial
Medicine FDA approves AJOVY for paediatric migraine prevention By admin August 13, 2025 0 Comment on FDA approves AJOVY for paediatric migraine prevention
Medicine Lilly and UK Government launch £85 million obesity care innovation programme By admin August 13, 2025 0 Comment on Lilly and UK Government launch £85 million obesity care innovation programme
Medicine Lilly’s Jaypirca shows positive results in phase 3 trial By admin August 12, 2025 0 Comment on Lilly’s Jaypirca shows positive results in phase 3 trial
Medicine Scotland approves zanubrutinib for relapsed mantle cell lymphoma By admin August 12, 2025 0 Comment on Scotland approves zanubrutinib for relapsed mantle cell lymphoma
Medicine Sever Pharma expands work on ketamine implant with Silo Pharma By admin August 11, 2025August 11, 2025 0 Comment on Sever Pharma expands work on ketamine implant with Silo Pharma
Medicine FDA expands AVTOZMA IV approval to include cytokine release syndrome By admin August 8, 2025 0 Comment on FDA expands AVTOZMA IV approval to include cytokine release syndrome
Medicine NICE backs KEYTRUDA combination for advanced endometrial cancer By admin August 7, 2025 0 Comment on NICE backs KEYTRUDA combination for advanced endometrial cancer
Medicine Porosome Therapeutics unveils breakthrough Alzheimer’s research By admin August 7, 2025 0 Comment on Porosome Therapeutics unveils breakthrough Alzheimer’s research
Medicine Nxera unveils proprietary pipeline targeting obesity and metabolic disorders By admin August 6, 2025 0 Comment on Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
Medicine Gedeon Richter launches Nalvee in UK to expand HRT options for menopause By admin August 6, 2025 0 Comment on Gedeon Richter launches Nalvee in UK to expand HRT options for menopause
Medicine Bath researchers develop pill-based alternative to injections By admin August 5, 2025 0 Comment on Bath researchers develop pill-based alternative to injections
Medicine Microbiotica completes recruitment for phase 1b ulcerative colitis trial By admin August 5, 2025 0 Comment on Microbiotica completes recruitment for phase 1b ulcerative colitis trial
Medicine US$30.9 million strategic equity deal strengthens Everest’s oncology platform By admin August 4, 2025 0 Comment on US$30.9 million strategic equity deal strengthens Everest’s oncology platform
Medicine Moderna wins EU approval for updated COVID-19 vaccine By admin August 1, 2025 0 Comment on Moderna wins EU approval for updated COVID-19 vaccine
Medicine Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease By admin July 31, 2025 0 Comment on Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease
Medicine NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer By admin July 31, 2025July 31, 2025 0 Comment on NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
Medicine Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial By admin July 30, 2025 0 Comment on Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial
Medicine PharmaTimes Clinical Researcher of the Year – The Americas By admin July 30, 2025 0 Comment on PharmaTimes Clinical Researcher of the Year – The Americas
Medicine Exonate to launch phase 2b trial of EXN407 for diabetic eye disease By admin July 29, 2025 0 Comment on Exonate to launch phase 2b trial of EXN407 for diabetic eye disease
Medicine Elizabeth Rebeil – PharmaTimes By admin July 29, 2025 0 Comment on Elizabeth Rebeil – PharmaTimes
Medicine Moderna’s updated COVID-19 vaccine receives positive EMA opinion By admin July 28, 2025 0 Comment on Moderna’s updated COVID-19 vaccine receives positive EMA opinion
Medicine Kling Bio partners with Sanofi to accelerate antibody discovery By admin July 25, 2025 0 Comment on Kling Bio partners with Sanofi to accelerate antibody discovery
Medicine Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy By admin July 24, 2025 0 Comment on Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy
Medicine Ovagen breakthrough boosts yellow fever vaccine yields By admin July 24, 2025 0 Comment on Ovagen breakthrough boosts yellow fever vaccine yields
Medicine 4TEEN4 begins trial of antibody therapy for cardiogenic shock By admin July 23, 2025 0 Comment on 4TEEN4 begins trial of antibody therapy for cardiogenic shock
Medicine PharmaTimes Clinical Researcher of the Year – The Americas By admin July 23, 2025 0 Comment on PharmaTimes Clinical Researcher of the Year – The Americas
Medicine PhoreMost unveils platform to streamline molecular glue drug discovery By admin July 22, 2025 0 Comment on PhoreMost unveils platform to streamline molecular glue drug discovery
Medicine Ezmekly becomes first approved EU therapy for NF1-PN in children and adults By admin July 22, 2025 0 Comment on Ezmekly becomes first approved EU therapy for NF1-PN in children and adults
Medicine AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025 By admin July 21, 2025 0 Comment on AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025
Medicine Proximie and HistoSonics partner to transform liver tumour treatment in US By admin July 20, 2025 0 Comment on Proximie and HistoSonics partner to transform liver tumour treatment in US
Medicine North East NHS launches digital platform to tackle chronic kidney disease By admin July 19, 2025 0 Comment on North East NHS launches digital platform to tackle chronic kidney disease
Medicine One Biosciences raises €15 million to advance single-cell oncology platform By admin July 19, 2025 0 Comment on One Biosciences raises €15 million to advance single-cell oncology platform
Medicine Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression By admin July 18, 2025 0 Comment on Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression
Medicine MHRA approves first oral treatment for hereditary angioedema attacks By admin July 16, 2025 0 Comment on MHRA approves first oral treatment for hereditary angioedema attacks
Medicine NHS England secures access to new cystic fibrosis treatment ALYFTREK By admin July 15, 2025 0 Comment on NHS England secures access to new cystic fibrosis treatment ALYFTREK
Medicine Imperial study reveals DNA structure that could reverse ovarian cancer resistance By admin July 15, 2025July 15, 2025 0 Comment on Imperial study reveals DNA structure that could reverse ovarian cancer resistance
Medicine Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer By admin July 14, 2025 0 Comment on Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer
Medicine Osivax publishes phase 2a results supporting dual flu vaccine approach By admin July 11, 2025 0 Comment on Osivax publishes phase 2a results supporting dual flu vaccine approach
Medicine Government to adopt EU standards for high-risk diagnostic devices By admin July 10, 2025July 10, 2025 0 Comment on Government to adopt EU standards for high-risk diagnostic devices
Medicine Actithera closes $75.5m Series A to advance radioligand therapy platform By admin July 10, 2025 0 Comment on Actithera closes $75.5m Series A to advance radioligand therapy platform
Medicine BiomX phage therapy shows potent effect in cystic fibrosis trial By admin July 9, 2025 0 Comment on BiomX phage therapy shows potent effect in cystic fibrosis trial
Medicine Clinical Researcher of the Year – The Americas By admin July 9, 2025 0 Comment on Clinical Researcher of the Year – The Americas
Medicine VarmX secures US approval to begin phase 3 trial of urgent surgery treatment By admin July 8, 2025 0 Comment on VarmX secures US approval to begin phase 3 trial of urgent surgery treatment
Medicine Eladynos recommended for osteoporosis treatment in Scottish NHS By admin July 8, 2025 0 Comment on Eladynos recommended for osteoporosis treatment in Scottish NHS
Medicine First patient dosed in trial for novel dry AMD treatment PST-611 By admin July 7, 2025 0 Comment on First patient dosed in trial for novel dry AMD treatment PST-611
Medicine First German haemophilia B patient receives gene therapy HEMGENIX By admin July 4, 2025July 4, 2025 0 Comment on First German haemophilia B patient receives gene therapy HEMGENIX
Medicine Dr Dietrich Stephan – PharmaTimes By admin July 3, 2025 0 Comment on Dr Dietrich Stephan – PharmaTimes
Medicine Neumifil shows promise in treating influenza with positive phase 2 dat By admin July 2, 2025 0 Comment on Neumifil shows promise in treating influenza with positive phase 2 dat
Medicine Moderna flu vaccine shows superior results in phase 3 study By admin July 2, 2025July 2, 2025 0 Comment on Moderna flu vaccine shows superior results in phase 3 study
Medicine Cidara and hVIVO report positive results in flu prevention study By admin July 1, 2025 0 Comment on Cidara and hVIVO report positive results in flu prevention study
Medicine UCB reports success in phase 3 study of fenfluramine for CDD By admin June 30, 2025 0 Comment on UCB reports success in phase 3 study of fenfluramine for CDD
Medicine Future prescribed – PharmaTimes By admin June 27, 2025 0 Comment on Future prescribed – PharmaTimes
Medicine NHS ConfedExpo 2025: a platform for change in UK health and care By admin June 26, 2025 0 Comment on NHS ConfedExpo 2025: a platform for change in UK health and care
Medicine Jessica Atkinson – PharmaTimes By admin June 25, 2025 0 Comment on Jessica Atkinson – PharmaTimes
Medicine Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health By admin June 25, 2025June 25, 2025 0 Comment on Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health
Medicine 2025 PharmaTimes Clinical Researcher of the Year By admin June 24, 2025 0 Comment on 2025 PharmaTimes Clinical Researcher of the Year
Medicine Ben Svarczkopf – PharmaTimes By admin June 24, 2025 0 Comment on Ben Svarczkopf – PharmaTimes
Medicine NHS rolls out new initiative to identify pancreatic cancer earlier By admin June 23, 2025June 23, 2025 0 Comment on NHS rolls out new initiative to identify pancreatic cancer earlier
Medicine Louise Peacock – PharmaTimes By admin June 20, 2025 0 Comment on Louise Peacock – PharmaTimes
Medicine Chris Brett – PharmaTimes By admin June 20, 2025June 20, 2025 0 Comment on Chris Brett – PharmaTimes
Medicine eXmoor and Signadori Bio enter cell therapy partnership By admin June 19, 2025June 19, 2025 0 Comment on eXmoor and Signadori Bio enter cell therapy partnership
Medicine Teva and Fosun Pharma partner on early-stage oncology drug By admin June 19, 2025 0 Comment on Teva and Fosun Pharma partner on early-stage oncology drug
Medicine FDA approves UroGen’s Zusduri to treat recurrent bladder cancer By admin June 18, 2025 0 Comment on FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
Medicine EDX medical partners with spire healthcare to advance disease diagnostics By admin June 17, 2025 0 Comment on EDX medical partners with spire healthcare to advance disease diagnostics
Medicine Investigational treatment shows promise for aggressive multiple myeloma By admin June 16, 2025 0 Comment on Investigational treatment shows promise for aggressive multiple myeloma
Medicine Dr Jason Slingsby – PharmaTimes By admin June 14, 2025 0 Comment on Dr Jason Slingsby – PharmaTimes
Medicine Argenx presents new efgartigimod data at EULAR 2025 By admin June 13, 2025 0 Comment on Argenx presents new efgartigimod data at EULAR 2025
Medicine Migraine takes the spotlight at European Parliament By admin June 13, 2025 0 Comment on Migraine takes the spotlight at European Parliament
Medicine Levicept presents new LEVI-04 data at EULAR By admin June 12, 2025June 12, 2025 0 Comment on Levicept presents new LEVI-04 data at EULAR
Medicine Bimekizumab shows lasting efficacy at EULAR 2025 By admin June 11, 2025 0 Comment on Bimekizumab shows lasting efficacy at EULAR 2025
Medicine Tagomics secures £860k grant for colorectal cancer test By admin June 10, 2025 0 Comment on Tagomics secures £860k grant for colorectal cancer test
Medicine PharmaTimes Clinical Researcher of the Year – The Americas By admin June 10, 2025 0 Comment on PharmaTimes Clinical Researcher of the Year – The Americas
Medicine Dr Jason Slingsby – PharmaTimes By admin June 9, 2025 0 Comment on Dr Jason Slingsby – PharmaTimes
Medicine NICE recommends Sogroya for growth hormone deficiency in children By admin June 6, 2025 0 Comment on NICE recommends Sogroya for growth hormone deficiency in children
Medicine Linear Diagnostics awarded £1m to develop rapid STI test By admin June 6, 2025 0 Comment on Linear Diagnostics awarded £1m to develop rapid STI test
Medicine EC approves Santen’s Ryjunea to slow progression of paediatric myopia By admin June 5, 2025 0 Comment on EC approves Santen’s Ryjunea to slow progression of paediatric myopia
Medicine Patient puzzle – PharmaTimes By admin June 5, 2025 0 Comment on Patient puzzle – PharmaTimes
Medicine PharmaTimes Clinical Researcher of the Year – The Americas By admin June 4, 2025 0 Comment on PharmaTimes Clinical Researcher of the Year – The Americas
Medicine AstraZeneca’s Forxiga recommended for chronic kidney disease treatment By admin June 3, 2025 0 Comment on AstraZeneca’s Forxiga recommended for chronic kidney disease treatment
Medicine NICE recommends mirikizumab for Crohn’s disease treatment By admin June 3, 2025 0 Comment on NICE recommends mirikizumab for Crohn’s disease treatment
Medicine Lumanity and Parker Institute partner to support delivery of new immunotherapies By admin May 30, 2025 0 Comment on Lumanity and Parker Institute partner to support delivery of new immunotherapies
Medicine Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain By admin May 29, 2025 0 Comment on Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain
Medicine TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform By admin May 29, 2025 0 Comment on TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform
Medicine Oxford Brain Diagnostics to launch groundbreaking dementia diagnosis technology By admin May 28, 2025 0 Comment on Oxford Brain Diagnostics to launch groundbreaking dementia diagnosis technology
Medicine NICE recommends sparsentan for IgA nephropathy By admin May 27, 2025 0 Comment on NICE recommends sparsentan for IgA nephropathy
Medicine Sonrai and AOA Dx partner to accelerate ovarian cancer test development By admin May 23, 2025May 23, 2025 0 Comment on Sonrai and AOA Dx partner to accelerate ovarian cancer test development
Medicine MHRA Board meets in Scotland for first time, reinforcing UK-wide health priorities By admin May 22, 2025May 22, 2025 0 Comment on MHRA Board meets in Scotland for first time, reinforcing UK-wide health priorities
Medicine Ionis shares phase 3 results for olezarsen in moderate hypertriglyceridaemia By admin May 22, 2025May 22, 2025 0 Comment on Ionis shares phase 3 results for olezarsen in moderate hypertriglyceridaemia
Medicine Elizabeth Rebeil – PharmaTimes By admin May 21, 2025 0 Comment on Elizabeth Rebeil – PharmaTimes
Medicine FDA approves Amneal’s self-administered migraine drug Brekiya By admin May 21, 2025 0 Comment on FDA approves Amneal’s self-administered migraine drug Brekiya
Medicine Massalia Therapeutics launches to advance novel treatments for complex conditions By admin May 20, 2025 0 Comment on Massalia Therapeutics launches to advance novel treatments for complex conditions
Medicine MHRA approves guselkumab for Crohn’s disease and ulcerative colitis By admin May 20, 2025May 20, 2025 0 Comment on MHRA approves guselkumab for Crohn’s disease and ulcerative colitis
Medicine AviadoBio opens UK trial for FTD gene therapy By admin May 16, 2025 0 Comment on AviadoBio opens UK trial for FTD gene therapy
Medicine Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment By admin May 15, 2025May 15, 2025 0 Comment on Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment
Medicine Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease By admin May 15, 2025 0 Comment on Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease
Medicine Rein Therapeutics initiates renew phase 2 trial for IPF treatment By admin May 14, 2025 0 Comment on Rein Therapeutics initiates renew phase 2 trial for IPF treatment
Medicine Apiary invests in life sciences marketing specialist performance-io By admin May 13, 2025May 13, 2025 0 Comment on Apiary invests in life sciences marketing specialist performance-io
Medicine Fiona Smith-Laittan – PharmaTimes By admin May 13, 2025 0 Comment on Fiona Smith-Laittan – PharmaTimes
Medicine iOnctura starts randomised phase 1/2 trial in lung cancer treatment By admin May 9, 2025May 9, 2025 0 Comment on iOnctura starts randomised phase 1/2 trial in lung cancer treatment
Medicine Amgen’s Tepezza granted marketing authorisation in the UK By admin May 9, 2025May 9, 2025 0 Comment on Amgen’s Tepezza granted marketing authorisation in the UK
Medicine PharmaTimes Clinical Researcher of the Year – The Americas Awards By admin May 8, 2025May 8, 2025 0 Comment on PharmaTimes Clinical Researcher of the Year – The Americas Awards
Medicine MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d By admin May 8, 2025 0 Comment on MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d
Medicine Johnson & Johnson submits application for subcutaneous Rybrevant dosing By admin May 7, 2025May 7, 2025 0 Comment on Johnson & Johnson submits application for subcutaneous Rybrevant dosing
Medicine Chiesi partners with Wirral Primary Care to improve COPD detection By admin May 7, 2025 0 Comment on Chiesi partners with Wirral Primary Care to improve COPD detection
Medicine Mosaic therapeutics expands pipeline with Astex deal By admin May 3, 2025 0 Comment on Mosaic therapeutics expands pipeline with Astex deal
Medicine Nice recommends first AI medical device for skin cancer diagnosis in the NHS By admin May 2, 2025 0 Comment on Nice recommends first AI medical device for skin cancer diagnosis in the NHS
Medicine Leqembi dosing proposal for Alzheimer’s treatment validated by MHRA By admin May 2, 2025May 2, 2025 0 Comment on Leqembi dosing proposal for Alzheimer’s treatment validated by MHRA
Medicine Hundreds of genetic links to osteoarthritis unlocked By admin May 1, 2025May 1, 2025 0 Comment on Hundreds of genetic links to osteoarthritis unlocked
Medicine Lynozyfic receives EU approval for relapsed multiple myeloma treatment By admin May 1, 2025 0 Comment on Lynozyfic receives EU approval for relapsed multiple myeloma treatment
Medicine Takeda’s Adcetris receives positive opinion for Hodgkin lymphoma treatment By admin April 30, 2025 0 Comment on Takeda’s Adcetris receives positive opinion for Hodgkin lymphoma treatment
Medicine Katharina Pink – PharmaTimes By admin April 29, 2025 0 Comment on Katharina Pink – PharmaTimes
Medicine Argenx receives positive CHMP opinion for CIDP treatment By admin April 29, 2025 0 Comment on Argenx receives positive CHMP opinion for CIDP treatment
Medicine UCL researchers launch congenital muscular dystrophy research programme By admin April 27, 2025 0 Comment on UCL researchers launch congenital muscular dystrophy research programme
Medicine Acoramidis approved for heart condition treatment By admin April 27, 2025April 27, 2025 0 Comment on Acoramidis approved for heart condition treatment
Medicine Mosaic therapeutics expands pipeline with Astex deal By admin April 26, 2025 0 Comment on Mosaic therapeutics expands pipeline with Astex deal
Medicine All systems go! – PharmaTimes By admin April 26, 2025 0 Comment on All systems go! – PharmaTimes
Medicine Patrick Daly – PharmaTimes By admin April 25, 2025April 25, 2025 0 Comment on Patrick Daly – PharmaTimes
Medicine Genomics study launches to optimise childhood cancer care in Ireland By admin April 25, 2025 0 Comment on Genomics study launches to optimise childhood cancer care in Ireland
Medicine Russell Abberley – PharmaTimes By admin April 23, 2025 0 Comment on Russell Abberley – PharmaTimes
Medicine Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine By admin April 23, 2025 0 Comment on Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
Medicine Aidan Synnott – PharmaTimes By admin April 18, 2025April 18, 2025 0 Comment on Aidan Synnott – PharmaTimes
Medicine FDA approves Click’s digital therapeutic for episodic migraine By admin April 17, 2025 0 Comment on FDA approves Click’s digital therapeutic for episodic migraine
Medicine Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients By admin April 17, 2025April 17, 2025 0 Comment on Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients
Medicine Leqembi approved as first treatment to slow early Alzheimer’s progression By admin April 16, 2025 0 Comment on Leqembi approved as first treatment to slow early Alzheimer’s progression
Medicine Global data highlights effectiveness of romosozumab By admin April 16, 2025 0 Comment on Global data highlights effectiveness of romosozumab
Medicine New data reinforce daratumumab as standard of care for multiple myeloma By admin April 15, 2025 0 Comment on New data reinforce daratumumab as standard of care for multiple myeloma
Medicine New test prototype for monitoring MGUS patients funded By admin April 15, 2025 0 Comment on New test prototype for monitoring MGUS patients funded
Medicine UK clinical trials regulations signed into law By admin April 14, 2025 0 Comment on UK clinical trials regulations signed into law
Medicine Lab-grown lung cancer cells show potential to revolutionise treatment By admin April 11, 2025 0 Comment on Lab-grown lung cancer cells show potential to revolutionise treatment
Medicine First treatment for common bladder cancer recommended by NICE By admin April 10, 2025 0 Comment on First treatment for common bladder cancer recommended by NICE
Medicine SkyCell and Microsoft partner to improve pharma supply chains By admin April 10, 2025 0 Comment on SkyCell and Microsoft partner to improve pharma supply chains
Medicine NHS launches spring COVID-19 booster campaign By admin April 9, 2025 0 Comment on NHS launches spring COVID-19 booster campaign
Medicine MHRA approves prostate cancer imaging agent trofolastat By admin April 8, 2025 0 Comment on MHRA approves prostate cancer imaging agent trofolastat
Medicine SMC approves bimekizumab for hidradenitis suppurativa treatment By admin April 8, 2025 0 Comment on SMC approves bimekizumab for hidradenitis suppurativa treatment
Medicine Endlyz Therapeutics emerges with pipeline for Parkinson’s disease By admin April 7, 2025 0 Comment on Endlyz Therapeutics emerges with pipeline for Parkinson’s disease
Medicine Aspire and inspire – PharmaTimes By admin April 5, 2025 0 Comment on Aspire and inspire – PharmaTimes
Medicine Elekta and Azra AI partner to advance cancer registry operations with AI By admin April 4, 2025 0 Comment on Elekta and Azra AI partner to advance cancer registry operations with AI
Medicine European Commission approves ustekinumab for paediatric Crohn’s disease By admin April 3, 2025 0 Comment on European Commission approves ustekinumab for paediatric Crohn’s disease
Medicine NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma By admin April 3, 2025April 3, 2025 0 Comment on NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
Medicine 4basebio receives MHRA licence for synthetic DNA manufacture By admin April 2, 2025 0 Comment on 4basebio receives MHRA licence for synthetic DNA manufacture
Medicine Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK By admin April 2, 2025 0 Comment on Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Medicine Amivantamab plus lazertinib shows survival benefit in lung cancer By admin March 28, 2025 0 Comment on Amivantamab plus lazertinib shows survival benefit in lung cancer
Medicine Genome editing offers hope for genetic hearing loss By admin March 27, 2025 0 Comment on Genome editing offers hope for genetic hearing loss
Medicine Nouscom reveals promising results for lynch syndrome immunotherapy By admin March 27, 2025March 27, 2025 0 Comment on Nouscom reveals promising results for lynch syndrome immunotherapy
Medicine Linda Härmark – PharmaTimes By admin March 26, 2025 0 Comment on Linda Härmark – PharmaTimes
